'A dose counter great relief to the great relief to the patient, because for the first time they actually know how much medication they have left in their rescue inhaler,'said Dr. Ketan K. Allergist with the Lafayette Allergy and Asthma clinic in Indianapolis. Treatment of asthma, serious consequences for the patients who reach for an empty canister, a sudden a sudden asthma symptoms. Ventolin HFA with dose counter, can help prevent patients this kind of situation and provide some peace of mind to physicians and patients. '.. The introduction of Ventolin HFA with dose counter, patients now have a reliable method to determine how many doses are left in their rescue medication and when it is time for a refill.
About Ventolin HFAVentolin HFA is an environmentally friendly formulation, developed in accordance with the Montreal Protocol decision on the use of propellants and contains hydrofluoroalkane to drive to the drug from the reservoir and into the lungs rather than a chlorofluorocarbon propellants, which had been referred to the ozone depletion in the atmosphere.- controlled by Our research to obesity, smoking, sedentary lifestyle and HbA1c level, and even found that depressed was connected to an increased risk of retinopathy, said co-author playLil Wayne Katon, MD.. Diabetic retinopathy occurs when diabetes is not managed properly and is now the leading cause of blindness in patients from 25 to 74 years, according to the survey appear online in the journal General Hospital Psychiatry.
With one five-point growth at the PHQ-9 visitors grew patients risk of diabetic retinopathy of up to 15 %. - Our findings can be its psychobiologic changes by depression like increased cortisol levels and activity of clotting factors assigned to the development of retinopathy connected, Katon said. There is no doubt that exposure of depression in patients is with diabetic very high and that depression is a risk factor for poorer outcomes in people with diabetes, of this study was, said Todd Brown, a, assistant professor of medicine in the Division of Endocrinology and Metabolism at the Johns Hopkins University.. Katon is the director of health and psychiatry epidemiology at the University of Washington Medical School in Seattle.